Compare Marvell Technology Inc (MRVL) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Tempus AI — how do they compare? Marvell Technology Inc trades at $279.94 (market cap $255.84B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Marvell Technology Inc is far larger — about 20× Tempus AI's market cap, and Marvell Technology Inc pays a 0.08% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marvell Technology Inc for 42 Days and Tempus AI for 22 Days on average.
| MRVL | TEM | |
|---|---|---|
Market Cap | $255.84B | $12.77B |
Volume | 23,652,500 | 8,980,490 |
Sector | Technology | Broad Market / Factor |
52-Week High | $316.43 | $99.28 |
52-Week Low | $73.73 | $41.55 |
Typical Hold Time | 42 Days | 22 Days |
Enterprise Value | $257.20B | $13.40B |
Dividend Yield | 0.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marvell Technology (MRVL) trades at $274.66, down 4.3% over 24 hours, amid strong bullish technical signals and robust analyst sentiment. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at 1.1. Revenue growth accelerated to 42% in fiscal 2026, driven by data center demand, while profitability metrics like a 52.21% gross margin underscore operational strength. Recent news highlights major custom AI chip deals, including a potential $120 billion agreement with Google.
Outlook remains positive given elevated AI infrastructure spending and raised fiscal 2028 revenue guidance to $18 billion. Risks include high valuation multiples (P/E of 94.26) and dependence on hyperscaler demand. With 84% analyst buy ratings and a $327.86 consensus target, the stock offers growth potential but requires monitoring of competitive and execution risks.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
